date/time interval
- February 1, 2022 - July 31, 2023
Discovery of new therapies for hypertrophic cardiomyopathy in RASopathies using hiPSC-based high throughput drug screening platform
Grant
Overview
awarded by
administered by
sponsor award ID
- NSA 223193-01
Affiliation
contributor
- Jaffré, Fabrice Principal Investigator 2022 - 2023